 - New clinical data highlight pelareoreps potential to boost the effectiveness of checkpoint inhibitors - Clinical demonstration of pelareorep reversing immunosuppressive tumor microenvironments - On track to report clinical biomarker and safety data in breast cancer in 2021 - Strong... 